Skip to content

Minimally invasive versus open pancreatoduodenectomy

Minimally invasive versus open pancreatoduodenectomy - LEOPARD-2 trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44749
Enrollment
136
Registered
2016-02-16
Start date
2016-03-02
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peri-ampullaire aandoeningen/tumoren/cysten cancer tumor

Interventions

Intervention: Minimally invasive pancreatoduodenectomy Control: Open pancreatoduodenectomy

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age equal or above 18 years • Indication for elective pancreatoduodenectomy because of a malignant, pre-malignant or symptomatic benign disease located in the pancreatic head, distal bile duct, duodenum or ampulla of Vater • The procedure can be performed both laparoscopically and open according to the local surgeon • Fit to undergo pancreatoduodenectomy according to the surgeon and anaesthetist

Exclusion criteria

Exclusion criteria: • A second cancer requiring resection during the same procedure • Administration of neo-adjuvant radiotherapy • Vascular involvement (portal vein, superior mesenteric vein, superior mesenteric artery or hepatic artery) • Pregnancy • Body mass index >35 kg/m2 • Participation in another study with interference of study outcomes

Design outcomes

Primary

MeasureTime frame
Phase 2: - IL-6 serum levels Phase 3: - Time to functional recovery, defined as: independently mobile (or as mobile as preoperatively), adequate pain control with only oral analgesia, the ability to maintain at least 50% of daily required caloric intake, no intravenous fluid administration, no signs of active infection.

Secondary

MeasureTime frame
- Clavien-Dindo III or higher complications - Individual complications - Mortality - Quality of life - Costs - Other operative outcomes - Other postoperative outcomes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)